ロード中...
Radiotherapy with or without temozolomide in elderly patients aged ≥ 70 years with glioblastoma
INTRODUCTION: Although the recommended optimal treatment of glioblastoma multiforme (GBM) is adjuvant chemoradiotherapy, trials in GBM have excluded patients older than 70 years. In this study, we aimed to assess overall survival (OS) and prognostic factors in elderly patients (≥ 70 years) with newl...
保存先:
| 出版年: | Contemp Oncol (Pozn) |
|---|---|
| 主要な著者: | , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Termedia Publishing House
2016
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5013689/ https://ncbi.nlm.nih.gov/pubmed/27647990 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/wo.2016.61569 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|